ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO462

Association of eGFR at Peritoneal Dialysis (PD) Catheter Insertion with PD-Related Complications

Session Information

  • Home Dialysis - 1
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Dhoot, Arti, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
  • Clarke, Alix, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Quinn, Robert R., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Oliver, Matthew J., Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Group or Team Name

  • North American PD Catheter Registry.
Background

Guidelines now reflect a shift towards an intent to defer dialysis strategy, irrespective of modality. In peritoneal dialysis (PD), this may increase the risk of early complications. The objective of this study was to determine if early PD-related complications were associated with eGFR prior to PD catheter insertion.

Methods

We conducted a retrospective study using the North American PD catheter registry across 23 sites. Patients undergoing PD catheter insertions were initially grouped by pre-dialysis eGFR < 9 ml/min and >10 ml/min. The eGFR was then analyzed as a continuous variable. The primary outcome was the occurrence of PD related complications within 90 days of insertion. Adjusted risk between eGFR and outcomes was calculated using cause-specific Cox models.

Results

Of 1,537 patients with first PD catheter insertions, 1033 (67%) had a pre-dialysis eGFR < 9 versus 504 (33%) with ≥ 10. Patients with eGFR < 9 were more likely to be younger (median age 60 vs.63), female (44 vs 32%) and have fewer comorbidities. There was no significant difference in PD related complications between the eGFR < 9 and eGFR ≥ 10 groups (aHR 1.12 [0.86, 1.45]). However, in the lower GFR group, which represented two-thirds of the population, there was an increased risk for every 1ml/min eGFR decline below 9ml/min (aHR 1.18 [1.09, 1.28]) (Figure 1). The most common PD-related complications included; flow restriction (7%), leak (3%) and pain (3%).

Conclusion

PD-related complications were similar when comparing an insertion eGFR of <9 to >10 ml/min. However, when assessing eGFR as a continuum, there was an increased risk of complications by 18% for each 1ml/min drop in GFR below 9ml/min suggesting intent to defer start targets should account for modality.